Interestingly, Erson-Omay et al. previously reported six ultra-mutated high-grade gliomas with a signature characterized by an increased proportion of C > A transversions associated with somatic mutations in the POLE exonuclease domain and, in three cases, a germline MSH6 mutation [21]. The gene discussed is POLE; the disease is central nervous system cancer.